Bronchodilator Efficacy of a Single-Dose 12/400-µg Formoterol/Budesonide Combination as a Dry Powder for Inhalation Delivered by Discair® in Adult Patients with Moderate-to-Severe Stable COPD: Open-Label, Single-Arm, Phase IV Trial

Makaleler > Tam Makale · 2019

Yazarlar: BİRSEN PINAR YILDIZ, MESUT BAYRAKTAROĞLU, DİDEM GÖRGÜN, Kıvanç YÜKSEL

CLINICAL DRUG INVESTIGATION, SCI Expanded İndekslerine Giren Dergi, Uluslararası, 2019